510(k) · Cleared
Recalled · Class II · 2012Ultrawave II EX 1320
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Quanta System Spa · GEX Powered Laser Surgical Instrument
Cleared on Jul 11, 2007 after a 110-day review. The FDA summary names its predicate without a number. 150 later devices descend from it. It has been recalled once.
- Decided
- Jul 11, 2007
- Review
- 110 days
- Class
- Class II
- Product code
- GEX
- Recalls
- 1
- Predicates
- 0
150 later devices descend from it, 4 citing it directly.
- This deviceK070805 Ultrawave II EX 1320Quanta System Spa · 2007
- Descendant · cites it directly · 112 of its ownK081352 Profile Multi-Platform SystemSciton, Inc · 2008
- Descendant · 2 generations on · 111 of its ownK101916 Joule Multi-Platform SystemSciton, Inc · 2011
- Descendant · cites it directly · 96 of its ownK083207 Ultrawave Iii EX 1320Quanta System Spa · 2008 · Recalled
- Descendant · 3 generations on · 70 of its ownK132806 Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014
- Descendant · 4 generations on · 62 of its ownK143723 SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP SpectroFotona D.D. · 2015
Showing 5 of 150 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 150 · See all- K081352Profile Multi-Platform SystemSciton, Inc · 2008 · cites it directly112descendants
- K101916Joule Multi-Platform SystemSciton, Inc · 2011 · 2 generations on111descendants
- K083207Ultrawave Iii EX 1320Quanta System Spa · 2008 · cites it directly96descendants
- K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014 · 3 generations on70descendants
- K143723SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP SpectroFotona D.D. · 2015 · 4 generations on62descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K070805 | Ultrawave II EX 1320 | Quanta System Spa | 2007 | — |
| +1 | K081352 | Profile Multi-Platform System | Sciton, Inc | 2008 | — |
| +2 | K101916 | Joule Multi-Platform System | Sciton, Inc | 2011 | — |
| +1 | K083207 | Ultrawave Iii EX 1320 | Quanta System Spa | 2008 | 1 |
| +3 | K132806 | Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser Handpiece | Fotona D.D. | 2014 | — |
| +4 | K143723 | SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP Spectro | Fotona D.D. | 2015 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 2 | 0 |
| 2014 | 3 | 0 |
| 2015 | 6 | 0 |
| 2016 | 3 | 0 |
| 2017 | 7 | 0 |
| 2018 | 10 | 0 |
| 2019 | 7 | 0 |
| 2020 | 13 | 0 |
| 2021 | 8 | 0 |
| 2022 | 22 | 0 |
| 2023 | 10 | 0 |
| 2024 | 17 | 0 |
| 2025 | 22 | 0 |
| 2026 | 15 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | Adept Medical Concept's Adept 1064/755 Laser Named without a submission number | |
| * | — | Sciton, Inc.'s Profile 1320 Laser Named without a submission number | |
| * | — | Altus Medical Inc.'s Altus Medical Coolidge Laser Systems and Accessories Named without a submission number | |
| * | — | Quanta System's Eterna Giovinezza System Named without a submission number | |
| * | — | Cynosure's YAG Family of Lasers Named without a submission number | |
| * | — | Cynosure Apogee Elite laser Named without a submission number |
What descends from it? (150)
See all 1504 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Nov 7, 2012 | Class II | Z-0693-2013 | Labeling False and Misleading | Quanta System S.p.A, Italy, is notifying U.S. consignees that their website contained promotional materials for products distributed in the U.S. which did not specify that some of the claims made therein were not meant to apply to the… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K081352 (Sciton, Inc, 2008) has gone furthest, with 112 descendants of its own.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
Nd:YAG 1064nm Intended for general surgical applications; dermatology/plastic surgery; endoscopic/laparoscopic surgery; general surgery; gynecology; ENT; hemostasis; neurosurgery; oculoplastics; pulmonary surgery; thoracic surgery; urology; and orthopedics. General Surgical Applications: Incision, excision, coagulation, hemostasis, vaporization, and/or ablation of soft tissue in dermatology/plastic surgery, endoscopic/laparoscopic general surgery…
Read the full statement (623 words)
Nd:YAG 1064nm
Intended for general surgical applications; dermatology/plastic surgery;
endoscopic/laparoscopic surgery; general surgery; gynecology; ENT; hemostasis;
neurosurgery; oculoplastics; pulmonary surgery; thoracic surgery; urology; and
orthopedics.
General Surgical Applications:
Incision, excision, coagulation, hemostasis, vaporization, and/or ablation of soft tissue in
dermatology/plastic surgery, endoscopic/laparoscopic general surgery, gastroenterology,
general surgery, gynecology, head and neck/-otorhinolaryngology (ENT), neurosurgery,
oculoplastics, orthopedics, pulmonary surgery, thoracic surgery and urology.
Dermatology/Plastic Surgery:
Coagulation and hemostasis of benign vascular lesions such as, but not limited to, port
wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg and spider
veins and poikiloderma of Civatte and treatment of benign cutaneous lesions such as
warts, scars, striae and psoriasis. It addition, the laser is intended for the treatment of
benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos
(sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin
tags, keratoses, tattoos (significant reduction in the intensity of blue and/or black
tattoos), and plaques.
The ULTRAWAVE II EX 1320 laser is also indicated for pigmented lesions to reduce
lesion size, for patients with lesions that would potentially benefit from aggressive
treatment, and for patients with lesions that have not responded to other laser
treatments.
The ULTRAWAVE H1 EX 1320 laser is also indicated for the treatment of facial wrinkles
and wrinkles such as, but not limited to, periocular and periorbital wrinkles.
The ULTRA4WAVE H EX 1320 is indicated for the removal of unwanted hair, for the
stable long-term, or permanent, hair reduction through selective targeting of melanin in
hair follicles, and for the treatment of pseudofolliculitis barbae (PFB).
The ULTRAWAVE II EX 1320 is indicated for the reduction of red pigmentation in
hypertrophic and keloid scars where vascularity is an integral part of the scar.
The ULTRAWAVE II EX 1320 is indicated for use on all skin types (Fitzpatrick I-VI)
including tanned skin, and the removal and permanent reduction of unwanted hair in
Fitzpatrick I-VI, including suntanned skin types.
Orthopedics:
Cutting, ablation, and/or hemostasis of intra-articular tissue in orthopedic surgical and
arthroscopic applications.
Pulmonary Surgery:
Palliative treatment of benign and malignant pulmonary airway obtructions, including
squamous cell carcinoma, adenocarcinoma, carcinoid, benign tumors, granulomas, and
benign strictures.
Thoracic Surgery:
Incision, excision, coagulating and vaporization of soft tissue. Thoracic applications,
including but not limited to, isolation of vessels for endarterectomy and/or by-pass
grafts, wedge resections, thoractomy, formation of pacemaker pockets; vaporization,
coagulation, incision/excision, debulking, and ablation of lung tissue (thoracoscopy).
Urology:
All applications including superficial urinary bladder tumors, invasive bladder
carcinoma, urethral strictures and lesions of the external genitalia (including condyloma
acuminate).
Nd:YAG 1320nm
Indicated for use in general surgery and dermatology for the incision, excision, ablation,
vaporization, coagulation and haemostasis of soft tissue. It is also indicated for the
treatment of periorbital and perioral wrinkles, fine lines and wrinkles, and the treatment
of back acne and atrophic acne scars.
Alexandrite 755nm
Intended for coagulation and hemostatis of vascular lesions and the removal and
permanent reduction of unwanted hair in Fitzpatrick skin types I-VI, including
suntanned skin types. Also indicated for pigmented lesions and wrinkles.
/PL
590-1200nm: 625-1200nm; 650-1200nm
Indicated for permanent hair reduction.
550-1200nm; 570-1200nm
Indicated for photocoagulation of dermatological vascular lesion ( i.e.,face telangiectasia),
photothermolysis of blood vessels (treatment of facial and leg veins), and treatment of
benign pigmented lesions.
400-1200nm
Indicated for inflammatory acne (acne vulgaris).
Integrated Skin Cooler
The intended use of the integrated cooling system in the ULTRAWAVE II EX 1320
hand piece is to provide cooling of the skin prior to laser treatment, for the reduction of pain
during laser treatment, to allow for the use of higher fluencies for laser treatments such
as hair removal and vascular lesion, and to reduce
the potential side effects of laser treatments.
Any other different use is considered incoimect.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K070805 · printed Nov 6, 2026
Cite this page
510(k) Report. “K070805: Ultrawave II EX 1320.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070805
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026